Claritas Pharmaceuticals Inc V.CLAS.H

Validation of hairinc's amazing analysis of Kalytera.

[SmellsFishy]

Hi, before I start.  Whenever you are buying a pharmaceutical company, there is risk involved.  When you buy a venture exchange cannabinoid company this risk is extreme and potential of a 100% lose is great.  Thankfully we have hairinc to help us with or decision making.  He helped us by pointing out that Kalytera is TRASH.   I'm certain hairinc thinks this stock is trash because Kalytera Therapeutics has on their staff Dr  Raphael Mecholam, one of the leading cannabidiol researchers in the world.  However, he is old and has been working on cannabinoid solutions for 50 years.  This is a huge negative, Dr Mecholam's age and experience makes them less likely to succeed.  Kalytera should look for someone younger with less experience.   That fact that Dr Mecholam also hold multiple  US patents concerning the medical us of cannabidiol dating back to 2002, once again confirms that this stock is trash.  I've added the patent #'s for those of you who want to validate this trash stock.  

- US 6,410,588. Cannabinoids as Anti-inflammatory agents 2002
- US 2007/0099987 treating or preventing diabetes with cannabidiol
- US 2003/0225156 Anti nausea and Anti vomiting activity of cannabidiol

Here is the patent link  https://www.cannabisinternational.org/patents.php

Here is the link to video of this old washed up doctor who has been working way too long in the cannabinoid field.   https://kalytera.co/about/ 

I really want to thank hairinc for his in depth analysis of Kalytera Therapeutics.   Thank goodness not too many people know about this company yet.  If they did, they might get scammed into buying these trash shares and artificially drive Up the price.